Given the loss of these populations in MDS, and to a lesser extent in CHIP (Fig. 3A, Supplementary Fig. 7B), indicates a reduced capacity of the stromal compartment to maintain HSPCs in CHIP, with this impairment being even more pronounced in MDS. This evidence concerns the gene STUB1 and myelodysplastic syndrome.